For decades , doctors have struggled to find viable solutions for treatment-resistant mood disorders. Now indicates this novel drug therapy, given typically through injection , can offer considerable opportunity for patients who haven’t responded from conventional antidepressants . Although still considered an innovative intervention, preliminary